re: big sirtex news-aussie funding reimbursement
AS the news was released 4 minutes before the close yesterday that The Australian Health Ministry will pay for Sirtex Sir Spheres product, this will add 24 more paying hospital centers whereby Sirtex gets about 10,000 x avg 1.7 treatments per patient= $ 17,000 per patient. With prevalebce of disease on the increase this should increase revenues and profits alot. Also the company and product is well entrenched in its native country. Already big growth in US is happening already at $14,000 per treatment and avg 1.7 treatments per patient or $24,000 USD per US patient.The co is only treating less than 0.5% of the eligible population at a profit already. With a float of 9.5 million shares and the rest tightly held chart suggests it could be quick move and after $2.55 there is no resistance until $3.50-3.80 a share. Now that revenues are increasing alot the story could be unfolding .
SRX Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held